Rating agency Crisil has lowered India's real gross domestic product (GDP) growth forecast to 7.3% from 7.8% for FY23 from 7.8 per cent estimated earlier.
Serum Institute of India (SII) to manufacture the indigenously-developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer. The Drugs Controller General of India (DCGI) approved India's first Quadri-valent Human Papillomavirus vaccine (qHPV) against cervical cancer.
EXAMIANS